MYC and chronic kidney disease: Specifically, in skeletal muscle of dialysis patients, there was upregulation of the interferon-α response and interferon-γ response pathways, which were downregulated in CKD patients; in contrast, the gene set Myc targets v1 was upregulated in CKD but downregulated with dialysis (Figure 4G).